0.3029
Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
96.11%
0.0118
|
0.3033 | 0.025 | 0.0433 | 0.2336 |
| Cost Of Revenue |
21.09%
0.0106
|
0.00873 | 0.00291 | 0.00334 | 0.0182 |
| Gross Profit |
99.58%
0.00123
|
0.2946 | 0.0221 | 0.04 | 0.2154 |
|
|
3.07%
3.7102
|
3.5999 | 4.8296 | 2.7301 | 2.5024 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
3.11%
3.7208
|
3.6086 | 4.8325 | 2.7334 | 2.5206 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Depreciation and Amortization |
0.24%
0.0526
|
0.0527 | 0.0518 | 0.0504 | 0.0483 |
| Operating Income/Loss |
12.21%
-3.709
|
-3.3053 | -4.8075 | -2.6901 | -2.287 |
| Net Interest Income/Expense |
21.88%
0.0577
|
0.0739 | 0.10 | 0.119 | 0.1585 |
|
|
3.35%
0.6707
|
0.649 | -0.5323 | 1.054 | 1.1956 |
| Income/Loss From Continuing Operations Before Tax |
100.44%
0.0118
|
-2.6563 | -5.3398 | 0.0433 | 0.2336 |
| Income/Loss From Continuing Operations After Tax |
14.38%
-3.0383
|
-2.6563 | -5.3398 | -1.6361 | -1.0914 |
|
|
14.38%
-3.0383
|
-2.6563 | -5.3398 | -1.6361 | -1.0914 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.30%
9.1162
|
8.7404 | 8.3571 | 0.1205 | 8.1215 |
| Diluted Average Shares |
4.30%
9.1162
|
8.7404 | 8.3571 | 0.1205 | 8.1215 |
| Basic Earnings Per Share |
10.00%
-0.33
|
-0.30 | -0.64 | -0.20 | -0.13 |
| Diluted Earnings Per Share |
10.00%
-0.33
|
-0.30 | -0.64 | -0.20 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):